Voestalpine AG (0MKX)
London Exchange · UK · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 42.13 |
|---|---|
| 52-week range | 29.86 – 49.06 |
| Return, 1 month / 3 months | −7.4% / −5.1% |
| Return, 1 year / 3 years | +38.0% / +94.3% |
| Trend | Below its 200-day average |
| RSI (14) | 39 |
| Volatility (1 year) | 36.7% |
| Worst drawdown (1 year) | -23.4% |
| Average daily value traded | 1.45M EUR |
| Dividend yield | 1.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Voestalpine AG is an Austrian steel and metal engineering group based in Linz. It makes steel products and develops metal components for industries including automotive, railway, construction and energy. Its operations span steel production, processing and specialised engineering, supplying manufacturers and infrastructure customers with rails, tubes, forged parts and precision components. The company serves industrial markets across Europe and other regions through its divisions, which cover steel, high-performance metals and metal engineering.
On this site Voestalpine AG appears as a stock on the London Exchange (UK), code 0MKX, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Voestalpine AG (0MKX) trades on the London Exchange in UK. It last closed at EUR 42.13 on 22 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 1,809 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 38.0% and over the last three months it fell 5.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 55 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -2.5% | ||
| From 52-week high | -13.3% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -5.1% | ||
| 6-month return | -0.5% | ||
| 12-month return, skipping the last month | 49.1% | ||
| Stability (higher is calmer) | 55 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 36.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.4% | ||
| Liquidity | 57 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.45M EUR | ||
| Zero-volume days | 8.3% | ||
| Income | 36 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.8% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −4.2% |
|---|---|
| 1 month | −7.4% |
| 3 months | −5.1% |
| 6 months | −0.5% |
| 1 year | +38.0% |
| 3 years | +94.3% |
| 5 years | +57.6% |
Signals
| 50-day / 200-day average | 44.88 / 43.21 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.51 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Jul 2026 | EUR 0.7500 |
| 10 Jul 2025 | EUR 0.6000 |
| 11 Jul 2024 | EUR 0.7000 |
| 13 Jul 2023 | EUR 1.5000 |
| 14 Jul 2022 | EUR 1.2000 |
| 15 Jul 2021 | EUR 0.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.